Doctor profile · Federal record
Dr. TANYA HARARI, DO
Rheumatology Physician (CMS: RHEUMATOLOGY) · WYNNEWOOD, PA
- NPI 1841727237
- Accepts Medicare
- MIPS 95.8 / 100 · 2023
- 9 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
100 E LANCASTER AVE STE 137
WYNNEWOOD, PA 190963453
(610) 896-8400
fax (610) 896-9652 - Mailing address
-
825 OLD LANCASTER RD STE 320
BRYN MAWR, PA 190103235
Credentials & registration
- NPI registered
- May 2017 — 9 yrs on file
- Profile last updated
- August 13, 2025
- Year of graduation
- 2017 — 9 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #OS022183
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1841727237. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
73,087
Distinct HCPCS
10
Medicare allowed
$837,156
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 44,101 | 50 | $10 | |
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20,000 | 13 | $5 | |
J0897 |
Injection, denosumab, 1 mg | 6,962 | 85 | $23 | |
96372 |
Injection of drug or substance under skin or into muscle | 522 | 127 | $15 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 444 | 235 | $131 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 317 | 41 | $1 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 190 | 190 | $173 | |
J3489 |
Injection, zoledronic acid, 1 mg | 170 | 34 | $8 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 110 | 14 | $77 | |
20610 |
Aspiration and/or injection of fluid from large joint | 75 | 46 | $74 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 4,092. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$5,979
Transactions
237
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 82 | $1,808.62 | |
| Amgen Inc. | 38 | $764.16 | |
| UCB, Inc. | 20 | $549.85 | |
| AstraZeneca Pharmaceuticals LP | 19 | $541.14 | |
| Novartis Pharmaceuticals Corporation | 17 | $399.64 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $275.98 | |
| Radius Health, Inc. | 11 | $212.48 | |
| Lilly USA, LLC | 13 | $191.86 | |
| PFIZER INC. | 12 | $189.09 | |
| Genentech USA, Inc. | 4 | $107.42 | |
| Mallinckrodt Hospital Products Inc. | 3 | $106.63 | |
| Sandoz Inc. | 5 | $90.79 | |
| ANI Pharmaceuticals, Inc. | 5 | $85.30 | |
| Organon Llc | 3 | $83.00 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $81.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
747
Patients
316
Total drug cost
$66,067
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 147 | 72 | $1,718 |
| Methotrexate (Methotrexate Sodium) | Brand | 99 | 29 | $4,721 |
| Hydroxychloroquine Sulfate | Generic | 86 | 37 | $6,516 |
| Gabapentin | Generic | 83 | 45 | $1,694 |
| Allopurinol | Generic | 57 | 16 | $895 |
| Methylprednisolone | Generic | 56 | 35 | $577 |
| Duloxetine Hcl | Generic | 44 | 17 | $1,870 |
| Diclofenac Sodium | Generic | 39 | 26 | $1,007 |
| Meloxicam | Generic | 24 | 12 | $76 |
| Leflunomide | Generic | 22 | 0 | $995 |